Tomato Juice for Health Study

NCT ID: NCT03783013

Last Updated: 2022-06-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

19 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-08

Study Completion Date

2021-08-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to determine if tomato-soy juice can reduce inflammation, which is linked to chronic disease

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to improve understanding of how diet can ameliorate the state of chronic inflammation. Short term inflammation is an important part of the body's response to injury, but long term inflammation, as happens in the state of obesity, can result in a multitude of secondary problems, like cancer, diabetes, and cardiovascular disease. Using a novel tomato-soy juice, we aim to demonstrate the potential of tomato-soy juice for reducing inflammation in adults.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No Soy and Low Lycopene Juice

Participants will consume two cans daily of a low lycopene tomato juice in addition to a diet low in lycopene and isoflavones.

Group Type OTHER

Low Lycopene Tomato Juice

Intervention Type OTHER

Tomato juice made from low lycopene tomatoes with no soy germ extract added

Soy and Lycopene Juice

Participants will consume two cans daily of a high lycopene tomato juice with added soy germ extract in addition to a diet low in lycopene and isoflavones.

Group Type OTHER

High Lycopene Tomato Juice With Soy Germ Extract

Intervention Type OTHER

Tomato juice made from high lycopene tomatoes with soy germ extract added

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High Lycopene Tomato Juice With Soy Germ Extract

Tomato juice made from high lycopene tomatoes with soy germ extract added

Intervention Type OTHER

Low Lycopene Tomato Juice

Tomato juice made from low lycopene tomatoes with no soy germ extract added

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between 30 and 75 years old
* Voluntarily agree to participate and sign an informed consent document

Exclusion Criteria

* Aged \< 30 years or \> 75 years
* Known allergy or intolerance to tomatoes or soy
* BMI \< 30 or \> 45 kg/m2
* Blood plasma glucose \> 125 mg/dL
* Blood plasma/serum triglycerides \> 250 mg/dL
* Blood plasma/serum cholesterol \> 240 mg/dL
* Diabetes requiring the use of diabetes pills, insulin, or non-insulin shots
* Previous bariatric or gastrointestinal surgery affecting absorption
* Suspected or known strictures, fistulas or physiological/mechanical gastrointestinal obstruction
* Presence of gastrointestinal or malabsorptive disorders (including Crohn's, ileus or ulcerative colitis, or diverticulitis), or nutrient malabsorption disease (such as celiac disease)
* Presence of autoimmune disease, metabolic disease, liver disorders, or kidney disorders
* Diagnosis or treatment of certain cancers in the past 3 years
* Use of tobacco products or marijuana
* Daily use of anti-inflammatory drugs
* Use of antibiotics over the previous 3 months
* Colonoscopy within a month of the study start date or during the study
* Use of a carotenoid or isoflavone-containing or metabolism-altering supplement for the last 1 month
* Use of certain medications (prescription or over-the-counter) that may interfere with the study objectives
* Unable or unwilling to give informed consent or communicate with study staff
* Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol
Minimum Eligible Age

30 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

USDA Beltsville Human Nutrition Research Center

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Janet Novotny

Research Physiologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

USDA-ARS Beltsville Human Nutrition Research Center

Beltsville, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HS61 - Tomato Juice Study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.